Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan
<p>Abstract</p> <p>Background</p> <p>Diabetic patients have a higher risk of bladder cancer and benign prostatic hyperplasia (BPH). Theoretically, BPH patients may have an increased risk of bladder cancer because residual urine in the bladder surely increases the contac...
Main Author: | Tseng Chin-Hsiao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/13/7 |
Similar Items
-
Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
by: JiHun Kang
Published: (2021-11-01) -
Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01) -
Does bladder outlet obstruction affect distance between the ureteric orifices in patients with benign prostate hyperplasia?
by: Cüneyt Özden, et al.
Published: (2009-01-01) -
Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction
by: Nishant D Patel, et al.
Published: (2014-01-01) -
The Influencing Role of Diabetes Mellitus and Hypertension in the Establishment of Benign Prostatic Hyperplasia
by: Ram Sagar Shah, et al.
Published: (2020-06-01)